During the past decade, Marietta Eye Clinic conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 10 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 10 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Marietta Eye Clinic" #1 sponsor was "Clearside Biomedical, Inc." with 5 trials, followed by "Jaeb Center for Health Research" with 5 trials sponsored, "Allergan" with 1 trials sponsored, "EyePoint Pharmaceuticals, Inc." with 1 trials sponsored and "Greater Houston Retina Research" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marietta Eye Clinic" #1 collaborator was "National Eye Institute (NEI)" with 5 trials as a collaborator, "National Institutes of Health (NIH)" with 5 trials as a collaborator, "Regeneron Pharmaceuticals" with 4 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 3 trials as a collaborator and "CBCC Global Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Marietta Eye Clinic" are "Diabetic Macular Edema" (4 trials), "Diabetic Retinopathy" (4 trials), "Uveitis, Posterior" (4 trials), "Panuveitis" (3 trials) and "Uveitis" (3 trials). Many other conditions were trialed in "Marietta Eye Clinic" in a lesser frequency.

Most popular intervention types in "Marietta Eye Clinic" are "Drug" (14 trials), "Procedure" (3 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "4 mg CLS-TA Suprachoriodal Injection" (2 trials), "Deferred aflibercept" (2 trials), "Deferred laser" (2 trials), "IVT aflibercept" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Marietta Eye Clinic" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Marietta Eye Clinic". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Marietta Eye Clinic, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Marietta Eye Clinic, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".